Please login to the form below

Not currently logged in
Email:
Password:

Neutec

This page shows the latest Neutec news and features for those working in and with pharma, biotech and healthcare.

Takeda grows in Turkey with Neutec subsidiary acquisition

Takeda grows in Turkey with Neutec subsidiary acquisition

Will acquire Toplam Kalite for up to 300m Turkish lira. Japan's Takeda has reached a deal to buy a subsidiary of Turkish pharma company Neutec, giving it a firmer foothold ... The acquired products will continue to be manufactured by Neutec, according to

Latest news

  • Novartis delivers confident outlook despite Chiron costs

    In June, Novartis offered to buy UK firm, NeuTec Pharma for?

  • Keeping afloat

    The higher losses were driven by additional manufacturing and approval costs for Mycograb, one of two drugs NeuTec is developing. ... NeuTec also has Aurograb, a drug being developed to attack the hospital superbug MRSA.

  • High hopes

    The FDA, however, rejected the claims. NeuTec losses widen. Among smaller stocks biopharmaceutical company, NeuTec Pharma, reported increased first-half losses. ... NeuTec is also pinning its hopes on Aurograb, for the treatment of the hospital super bug

  • Stormy seas ahead

    NeuTec Pharma soars on bid talks. NeuTec Pharma, the AIM-listed biotech company, saw its share price rise astronomically by 422p to £10.80p after announcing it is in bid talks. ... Hopeful punters reckon a bid war could develop, pushing NeuTec's share

  • Rocky Road

    and Neutec Pharma going to Novartis for £305m a fortnight ago.

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics